|
|
|
|
| LEADER |
00768 a2200217 4500 |
| 005 |
20151026133047.0 |
| 008 |
120627t xxu||||| |||| 00| 0 eng d |
| 080 |
|
|
|a 575.111:615
|b MIS
|
| 100 |
|
|
|a Misra, Ambikanandan; ed.
|e ed.by
|9 20744
|
| 245 |
|
|
|a Challenges in delivery of therapeutic genomics and proteomics
|
| 300 |
|
|
|a xiv, 671p.
|
| 490 |
|
|
|a Elesevier insights series
|
| 653 |
|
|
|a Pharmaceutical biotechnology
|
| 653 |
|
|
|a Geomics-gene therapy
|
| 653 |
|
|
|a Protein drugs
|
| 653 |
|
|
|a Proteomics
|
| 942 |
|
|
|c BK
|6 _
|
| 260 |
|
|
|b Elsevier
|c 2011
|a Massachusetts
|9 20745
|
| 020 |
|
|
|a 9780123849649
|
| 999 |
|
|
|c 62411
|d 62411
|
| 952 |
|
|
|0 0
|1 0
|2 udc
|4 0
|6 575111615_MIS
|7 0
|9 74964
|a UL
|b UL
|c GEN
|d 2012-01-18
|e 117
|g 0.00
|o 575.111:615 MIS
|p 00066953
|r 2012-01-18
|v 0.00
|w 2012-01-18
|y BK
|